Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 1/2020

01-01-2020 | Shock | Original Article

Effect of non-absorbent intravaginal menstrual/contraceptive products on Staphylococcus aureus and production of the superantigen TSST-1

Author: Patrick M. Schlievert

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 1/2020

Login to get access

Abstract

Tampons are associated with toxic shock syndrome (mTSS). One reason for this association is oxygen introduction within tampons into the anaerobic vagina. Oxygen is required for Staphylococcus aureus to produce TSS toxin-1 (TSST-1). There have been changes in use of medical devices to control menstrual flow, including increased use of menstrual discs and cups. These devices composed of solid, flexible materials do not absorb menstrual fluid and thus do not trap oxygen. This study evaluates tampons and non-absorbent devices for effect on S. aureus and TSST-1 production. There are three in vitro tests to evaluate devices for effect on TSST-1 production: (1) stationary flask, (2) shake flask, and (3) tampon sac. In this study, 100% rayon and 100% cotton tampons with three absorbencies, contraceptive diaphragms, and menstrual discs and cups were tested for effect on S. aureus growth and TSST-1 production. Product composition did not affect bacterial growth or TSST-1 production. Tampons showed no effect on S. aureus growth compared with no-tampon controls, but tampons showed enhanced TSST-1 production as a function of trapped oxygen in stationary cultures and tampon sacs but not in shake flasks. The non-absorbent devices showed no enhanced S. aureus growth or TSST-1 production compared with no-device controls. These studies are consistent with the association of tampons with mTSS as a function of absorbency, but they suggest the occasional association of mTSS with non-absorbent devices may be coincidental as opposed to co-causative.
Literature
1.
go back to reference Shands KN, Schmid GP, Dan BB, Blum D, Guidotti RJ, Hargrett NT, Anderson RL, Hill DL, Broome CV, Band JD et al (1980) Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl J Med 303(25):1436–1442PubMedCrossRef Shands KN, Schmid GP, Dan BB, Blum D, Guidotti RJ, Hargrett NT, Anderson RL, Hill DL, Broome CV, Band JD et al (1980) Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl J Med 303(25):1436–1442PubMedCrossRef
2.
go back to reference Davis JP, Chesney PJ, Wand PJ, LaVenture M (1980) The investigation and laboratory team. Toxic shock syndrome: epidemiological features, recurrence, risk factors, and prevention. N Engl J Med 303(25):1429–1435PubMedCrossRef Davis JP, Chesney PJ, Wand PJ, LaVenture M (1980) The investigation and laboratory team. Toxic shock syndrome: epidemiological features, recurrence, risk factors, and prevention. N Engl J Med 303(25):1429–1435PubMedCrossRef
3.
go back to reference Schlievert PM, Shands KN, Dan BB, Schmid GP, Nishimura RD (1981) Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J Infect Dis 143(4):509–516PubMedCrossRef Schlievert PM, Shands KN, Dan BB, Schmid GP, Nishimura RD (1981) Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J Infect Dis 143(4):509–516PubMedCrossRef
4.
go back to reference Kreiswirth BN, Lofdahl S, Betley MJ, O’Reilly M, Schlievert PM, Bergdoll MS, Novick RP (1983) The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature 305(5936):709–712PubMedCrossRef Kreiswirth BN, Lofdahl S, Betley MJ, O’Reilly M, Schlievert PM, Bergdoll MS, Novick RP (1983) The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature 305(5936):709–712PubMedCrossRef
5.
go back to reference Reingold AL, Hargrett NT, Shands KN, Dan BB, Schmid GP, Strickland BY, Broome CV (1982) Toxic shock syndrome surveillance in the United States, 1980 to 1981. Ann Intern Med 96(6 Pt 2):875–880PubMedCrossRef Reingold AL, Hargrett NT, Shands KN, Dan BB, Schmid GP, Strickland BY, Broome CV (1982) Toxic shock syndrome surveillance in the United States, 1980 to 1981. Ann Intern Med 96(6 Pt 2):875–880PubMedCrossRef
6.
go back to reference Davis JP, Chesney PJ, Wand PJ, LaVenture M (1980) Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention. N Engl J Med 303(25):1429–1435PubMedCrossRef Davis JP, Chesney PJ, Wand PJ, LaVenture M (1980) Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention. N Engl J Med 303(25):1429–1435PubMedCrossRef
7.
go back to reference Davis JP, Osterholm MT, Helms CM, Vergeront JM, Wintermeyer LA, Forfang JC, Judy LA, Rondeau J, Schell WL (1982) Tri-state toxic-shock syndrome study. II. Clinical and laboratory findings. J Infect Dis 145(4):441–448PubMedCrossRef Davis JP, Osterholm MT, Helms CM, Vergeront JM, Wintermeyer LA, Forfang JC, Judy LA, Rondeau J, Schell WL (1982) Tri-state toxic-shock syndrome study. II. Clinical and laboratory findings. J Infect Dis 145(4):441–448PubMedCrossRef
8.
go back to reference Osterholm MT, Davis JP, Gibson RW, Mandel JS, Wintermeyer LA, Helms CM, Forfang JC, Rondeau J, Vergeront JM (1982) Tri-state toxic-state syndrome study. I. Epidemiologic findings. J Infect Dis 145(4):431–440PubMedCrossRef Osterholm MT, Davis JP, Gibson RW, Mandel JS, Wintermeyer LA, Helms CM, Forfang JC, Rondeau J, Vergeront JM (1982) Tri-state toxic-state syndrome study. I. Epidemiologic findings. J Infect Dis 145(4):431–440PubMedCrossRef
9.
go back to reference Mills JT, Parsonnet J, Kass EH (1986) Production of toxic-shock-syndrome toxin-1: effect of magnesium ion. J Infect Dis 153(5):993–994PubMedCrossRef Mills JT, Parsonnet J, Kass EH (1986) Production of toxic-shock-syndrome toxin-1: effect of magnesium ion. J Infect Dis 153(5):993–994PubMedCrossRef
10.
go back to reference Broome CV, Hayes PS, Ajello GW, Feeley JC, Gibson RJ, Graves LM, Hancock GA, Anderson RL, Highsmith AK, Mackel DC et al (1982) In-vitro studies of interactions between tampons and Staphylococcus aureus. Ann Intern Med 96(6 Pt 2):959–962PubMedCrossRef Broome CV, Hayes PS, Ajello GW, Feeley JC, Gibson RJ, Graves LM, Hancock GA, Anderson RL, Highsmith AK, Mackel DC et al (1982) In-vitro studies of interactions between tampons and Staphylococcus aureus. Ann Intern Med 96(6 Pt 2):959–962PubMedCrossRef
11.
go back to reference Tierno PM Jr, Hanna BA (1985) In vitro amplification of toxic shock syndrome toxin-1 by intravaginal devices. Contraception 31(2):185–194PubMedCrossRef Tierno PM Jr, Hanna BA (1985) In vitro amplification of toxic shock syndrome toxin-1 by intravaginal devices. Contraception 31(2):185–194PubMedCrossRef
12.
go back to reference Tierno PM Jr, Hanna BA (1986) Magnesium and the production of toxic-shock-syndrome toxin-1 by Staphylococcus aureus. J Infect Dis 153(5):994–996PubMedCrossRef Tierno PM Jr, Hanna BA (1986) Magnesium and the production of toxic-shock-syndrome toxin-1 by Staphylococcus aureus. J Infect Dis 153(5):994–996PubMedCrossRef
13.
14.
go back to reference Tierno PM, Hanna BA (1983) Enzymic hydrolysis of tampon carboxymethylcellulose and toxic shock syndrome. Lancet 1(8338):1379–1380PubMedCrossRef Tierno PM, Hanna BA (1983) Enzymic hydrolysis of tampon carboxymethylcellulose and toxic shock syndrome. Lancet 1(8338):1379–1380PubMedCrossRef
15.
go back to reference Schlievert PM, Blomster DA (1983) Production of staphylococcal pyrogenic exotoxin type C: influence of physical and chemical factors. J Infect Dis 147(2):236–242PubMedCrossRef Schlievert PM, Blomster DA (1983) Production of staphylococcal pyrogenic exotoxin type C: influence of physical and chemical factors. J Infect Dis 147(2):236–242PubMedCrossRef
16.
go back to reference Pragman AA, Yarwood JM, Tripp TJ, Schlievert PM (2004) Characterization of virulence factor regulation by SrrAB, a two-component system in Staphylococcus aureus. J Bacteriol 186(8):2430–2438PubMedPubMedCentralCrossRef Pragman AA, Yarwood JM, Tripp TJ, Schlievert PM (2004) Characterization of virulence factor regulation by SrrAB, a two-component system in Staphylococcus aureus. J Bacteriol 186(8):2430–2438PubMedPubMedCentralCrossRef
17.
go back to reference Yarwood JM, McCormick JK, Schlievert PM (2001) Identification of a novel two-component regulatory system that acts in global regulation of virulence factors of Staphylococcus aureus. J Bacteriol 183(4):1113–1123PubMedPubMedCentralCrossRef Yarwood JM, McCormick JK, Schlievert PM (2001) Identification of a novel two-component regulatory system that acts in global regulation of virulence factors of Staphylococcus aureus. J Bacteriol 183(4):1113–1123PubMedPubMedCentralCrossRef
18.
go back to reference Yarwood JM, Schlievert PM (2000) Oxygen and carbon dioxide regulation of toxic shock syndrome toxin 1 production by Staphylococcus aureus MN8. J Clin Microbiol 38(5):1797–1803PubMedPubMedCentralCrossRef Yarwood JM, Schlievert PM (2000) Oxygen and carbon dioxide regulation of toxic shock syndrome toxin 1 production by Staphylococcus aureus MN8. J Clin Microbiol 38(5):1797–1803PubMedPubMedCentralCrossRef
19.
go back to reference Parsonnet J, Modern PA, Giacobbe KD (1996) Effect of tampon composition on production of toxic shock syndrome toxin-1 by Staphylococcus aureus in vitro. J Infect Dis 173(1):98–103PubMedCrossRef Parsonnet J, Modern PA, Giacobbe KD (1996) Effect of tampon composition on production of toxic shock syndrome toxin-1 by Staphylococcus aureus in vitro. J Infect Dis 173(1):98–103PubMedCrossRef
20.
go back to reference Fischetti VA, Chapman F, Kakani R, James J, Grun E, Zabriskie JB (1989) Role of air in growth and production of toxic shock syndrome toxin 1 by Staphylococcus aureus in experimental cotton and rayon tampons. Rev Infect Dis 11(Suppl 1):S176–S181PubMedCrossRef Fischetti VA, Chapman F, Kakani R, James J, Grun E, Zabriskie JB (1989) Role of air in growth and production of toxic shock syndrome toxin 1 by Staphylococcus aureus in experimental cotton and rayon tampons. Rev Infect Dis 11(Suppl 1):S176–S181PubMedCrossRef
21.
22.
go back to reference Reingold AL, Broome CV, Gaventa S, Hightower AW (1989) Risk factors for menstrual toxic shock syndrome: results of a multistate case-control study. Rev Infect Dis 11(Suppl 1):S35–S41 discussion S41–32PubMedCrossRef Reingold AL, Broome CV, Gaventa S, Hightower AW (1989) Risk factors for menstrual toxic shock syndrome: results of a multistate case-control study. Rev Infect Dis 11(Suppl 1):S35–S41 discussion S41–32PubMedCrossRef
23.
go back to reference Nonfoux L, Chiaruzzi M, Badiou C, Baude J, Tristan A, Thioulouse J, Muller D, Prigent Combaret C, Lina G (2018) Impact of currently marketed tampons and menstrual cups on Staphylococcus aureus growth and TSST-1 production in vitro. Appl Environ Microbiol(84):e00351-18PubMedPubMedCentralCrossRef Nonfoux L, Chiaruzzi M, Badiou C, Baude J, Tristan A, Thioulouse J, Muller D, Prigent Combaret C, Lina G (2018) Impact of currently marketed tampons and menstrual cups on Staphylococcus aureus growth and TSST-1 production in vitro. Appl Environ Microbiol(84):e00351-18PubMedPubMedCentralCrossRef
24.
go back to reference Hill DR, Brunner ME, Schmitz DC, Davis CC, Flood JA, Schlievert PM, Wang-Weigand SZ, Osborn TW (2005) In vivo assessment of human vaginal oxygen and carbon dioxide levels during and post menses. J Appl Physiol (1985) 99(4):1582–1591CrossRef Hill DR, Brunner ME, Schmitz DC, Davis CC, Flood JA, Schlievert PM, Wang-Weigand SZ, Osborn TW (2005) In vivo assessment of human vaginal oxygen and carbon dioxide levels during and post menses. J Appl Physiol (1985) 99(4):1582–1591CrossRef
25.
go back to reference Schlievert PM, Kelly JA (1984) Clindamycin-induced suppression of toxic-shock syndrome--associated exotoxin production. J Infect Dis 149(3):471PubMedCrossRef Schlievert PM, Kelly JA (1984) Clindamycin-induced suppression of toxic-shock syndrome--associated exotoxin production. J Infect Dis 149(3):471PubMedCrossRef
26.
go back to reference Schlievert PM, Blomster DA, Kelly JA (1984) Toxic shock syndrome Staphylococcus aureus: effect of tampons on toxic shock syndrome toxin 1 production. Obstet Gynecol 64(5):666–671PubMed Schlievert PM, Blomster DA, Kelly JA (1984) Toxic shock syndrome Staphylococcus aureus: effect of tampons on toxic shock syndrome toxin 1 production. Obstet Gynecol 64(5):666–671PubMed
27.
go back to reference Lee AC, Crass BA, Bergdoll MS (1987) Investigation by syringe method of effect of tampons on production in vitro of toxic shock syndrome toxin 1 by Staphylococcus aureus. J Clin Microbiol 25(1):87–90PubMedPubMedCentralCrossRef Lee AC, Crass BA, Bergdoll MS (1987) Investigation by syringe method of effect of tampons on production in vitro of toxic shock syndrome toxin 1 by Staphylococcus aureus. J Clin Microbiol 25(1):87–90PubMedPubMedCentralCrossRef
28.
go back to reference O’Reilly M, Kreiswirth B, Foster TJ (1990) Cryptic alpha-toxin gene in toxic shock syndrome and septicaemia strains of Staphylococcus aureus. Mol Microbiol 4(11):1947–1955PubMedCrossRef O’Reilly M, Kreiswirth B, Foster TJ (1990) Cryptic alpha-toxin gene in toxic shock syndrome and septicaemia strains of Staphylococcus aureus. Mol Microbiol 4(11):1947–1955PubMedCrossRef
29.
go back to reference Schlievert PM, Strandberg KL, Lin YC, Peterson ML, Leung DY (2010) Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis. J Allergy Clin Immunol 125(1):39–49PubMedPubMedCentralCrossRef Schlievert PM, Strandberg KL, Lin YC, Peterson ML, Leung DY (2010) Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis. J Allergy Clin Immunol 125(1):39–49PubMedPubMedCentralCrossRef
31.
go back to reference Schlievert PM, Nemeth KA, Davis CC, Peterson ML, Jones BE (2010) Staphylococcus aureus exotoxins are present in vivo in tampons. Clin Vaccine Immunol 17(5):722–727PubMedPubMedCentralCrossRef Schlievert PM, Nemeth KA, Davis CC, Peterson ML, Jones BE (2010) Staphylococcus aureus exotoxins are present in vivo in tampons. Clin Vaccine Immunol 17(5):722–727PubMedPubMedCentralCrossRef
32.
go back to reference Schlievert PM, Case LC, Strandberg KL, Tripp TJ, Lin YC, Peterson ML (2007) Vaginal Staphylococcus aureus superantigen profile shift from 1980 and 1981 to 2003, 2004, and 2005. J Clin Microbiol 45(8):2704–2707PubMedPubMedCentralCrossRef Schlievert PM, Case LC, Strandberg KL, Tripp TJ, Lin YC, Peterson ML (2007) Vaginal Staphylococcus aureus superantigen profile shift from 1980 and 1981 to 2003, 2004, and 2005. J Clin Microbiol 45(8):2704–2707PubMedPubMedCentralCrossRef
33.
go back to reference Schlievert PM, Tripp TJ, Peterson ML (2004) Reemergence of staphylococcal toxic shock syndrome in Minneapolis-St. Paul, Minnesota, during the 2000-2003 surveillance period. J Clin Microbiol 42(6):2875–2876PubMedPubMedCentralCrossRef Schlievert PM, Tripp TJ, Peterson ML (2004) Reemergence of staphylococcal toxic shock syndrome in Minneapolis-St. Paul, Minnesota, during the 2000-2003 surveillance period. J Clin Microbiol 42(6):2875–2876PubMedPubMedCentralCrossRef
34.
go back to reference Schlievert PM (1995) Comparison of cotton and cotton/rayon tampons for effect on production of toxic shock syndrome toxin. J Infect Dis 172(4):1112–1114PubMedCrossRef Schlievert PM (1995) Comparison of cotton and cotton/rayon tampons for effect on production of toxic shock syndrome toxin. J Infect Dis 172(4):1112–1114PubMedCrossRef
Metadata
Title
Effect of non-absorbent intravaginal menstrual/contraceptive products on Staphylococcus aureus and production of the superantigen TSST-1
Author
Patrick M. Schlievert
Publication date
01-01-2020
Publisher
Springer Berlin Heidelberg
Keywords
Shock
Shock
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 1/2020
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-019-03685-x

Other articles of this Issue 1/2020

European Journal of Clinical Microbiology & Infectious Diseases 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine